Literature DB >> 25161061

Modulation of mast cell proliferative and inflammatory responses by leukotriene d4 and stem cell factor signaling interactions.

Nosayba Al-Azzam1, Vinay Kondeti, Ernest Duah, Farai Gombedza, Charles K Thodeti, Sailaja Paruchuri.   

Abstract

Mast cells (MCs) are important effector cells in asthma and pulmonary inflammation, and their proliferation and maturation is maintained by stem cell factor (SCF) via its receptor, c-Kit. Cysteinyl leukotrienes (cys-LTs) are potent inflammatory mediators that signal through CysLT1 R and CysLT2 R located on the MC surface, and they enhance MC inflammatory responses. However, it is not known if SCF and cys-LTs cross-talk and influence MC hyperplasia and activation in inflammation. Here, we report the concerted effort of the growth factor SCF and the inflammatory mediator LTD4 in MC activation. Stimulation of MCs by LTD4 in the presence of SCF enhances c-Kit-mediated proliferative responses. Similarly, SCF synergistically enhances LTD4 -induced calcium, c-fos expression and phosphorylation, as well as MIP1β generation in MCs. These findings suggest that integration of SCF and LTD4 signals may contribute to MC hyperplasia and hyper-reactivity during airway hyper-response and inflammation.
© 2014 Wiley Periodicals, Inc., A Wiley Company.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25161061      PMCID: PMC4244248          DOI: 10.1002/jcp.24777

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  42 in total

Review 1.  Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses.

Authors:  Christine Tkaczyk; Bettina M Jensen; Shoko Iwaki; Alasdair M Gilfillan
Journal:  Immunol Allergy Clin North Am       Date:  2006-08       Impact factor: 3.479

Review 2.  Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses.

Authors:  Michele A Grimbaldeston; Martin Metz; Mang Yu; Mindy Tsai; Stephen J Galli
Journal:  Curr Opin Immunol       Date:  2006-10-02       Impact factor: 7.486

Review 3.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Cutting edge: Interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling.

Authors:  Yongfeng Jiang; Yoshihide Kanaoka; Chunl Feng; Karl Nocka; Sudhir Rao; Joshua A Boyce
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 5.  Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation.

Authors:  Bettina M Jensen; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Inflamm Allergy Drug Targets       Date:  2007-03

6.  Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation.

Authors:  Bettina M Jensen; Michael A Beaven; Shoko Iwaki; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Pharmacol Exp Ther       Date:  2007-10-09       Impact factor: 4.030

7.  Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation.

Authors:  Daniel C Kim; F Ida Hsu; Nora A Barrett; Daniel S Friend; Roland Grenningloh; I-Cheng Ho; Amal Al-Garawi; Jose M Lora; Bing K Lam; K Frank Austen; Yoshihide Kanaoka
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

8.  Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.

Authors:  Sailaja Paruchuri; Yongfeng Jiang; Chunli Feng; Sanjeev A Francis; Jorge Plutzky; Joshua A Boyce
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

9.  Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists.

Authors:  Elizabeth A Mellor; K Frank Austen; Joshua A Boyce
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cells.

Authors:  Vinay Kondeti; Ernest Duah; Nosayba Al-Azzam; Charles K Thodeti; Joshua A Boyce; Sailaja Paruchuri
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more
  6 in total

Review 1.  Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function.

Authors:  Joseph M Kulinski; Rosa Muñoz-Cano; Ana Olivera
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

2.  Montelukast, an Antagonist of Cysteinyl Leukotriene Signaling, Impairs Burn Wound Healing.

Authors:  Alan V Nguyen; Michelle D Bagood; Marilyn Wang; Sofia E Caryotakis; Glendalyn Smith; Shannon Yee; Haitao Shen; R Rivkah Isseroff; Athena M Soulika
Journal:  Plast Reconstr Surg       Date:  2022-05-10       Impact factor: 5.169

3.  Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.

Authors:  Vinay Kondeti; Nosayba Al-Azzam; Ernest Duah; Charles K Thodeti; Joshua A Boyce; Sailaja Paruchuri
Journal:  J Allergy Clin Immunol       Date:  2015-08-05       Impact factor: 10.793

Review 4.  Regulation of inflammation by lipid mediators in oral diseases.

Authors:  S Sommakia; O J Baker
Journal:  Oral Dis       Date:  2016-08-04       Impact factor: 3.511

5.  Scrodentoid A Inhibits Mast Cell-Mediated Allergic Response by Blocking the Lyn-FcεRIβ Interaction.

Authors:  Fei Qian; Liuqiang Zhang; Shaodong Lu; Gaohui Mao; Fujiang Guo; Ping Liu; Jinwen Xu; Yiming Li
Journal:  Front Immunol       Date:  2019-05-16       Impact factor: 7.561

6.  Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.

Authors:  Jun Liu; Zheng Chen; Wenli Li
Journal:  J Oncol       Date:  2021-03-17       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.